Plandai Biotechnology Inc (PLPL)

[Aston Martin]

The problem with PLPL - as with many penny plays - is, that they do not tell honestly how all those - if true - clinical tests, laboratory investigations, qualified elaborations of medicinal categorizations are paid....but by endless dilution on the shoulder of a non-profit stock since many years. Plandai annouces since years all those trials, tests etc. and burns money by increasing OS and ... well, and what else? There is no investor at all who puts money into PLPL. The money of South Africa bank is all burned. IF this tea extracts story has any tiny value, that Plandai management should learn to concentrate on first first products for some revenues. They remind me on explorere at Canada, who buy and buy endless properties...and by this they burn all the money insteed of doing some explorations. Finally they are bancrupt. This is what I worry here: This management is getting bogged down in details just to annouces wonderful news (Just read the wordings carefully ....an endless repetition of the same content since years). IF there has been any substance in a PLPL product, they seem to have no clue how to concentrate on a cautious approach. Those who are running a company will undersatnd my opinion.
But, as always, the charts speaks the truth.